Interview: Takeda Pharmaceutical CMSO Andrew Plump Talks R&D Strategy Feb. 1, 2018 Takeda Pharmaceutical Co. Ltd. (TYO:4502) has been undertaking a major restructuring of its R&D operations since 2016. The Chemical Daily…... Please subscribe to read the full story. Subscribe Free Trial